Net survival in survival analyses for patients with cancer : a scoping review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/245374 |
Resumo: | Population-based net survival is an important tool for assessing prognostic advances. The unbiased Pohar Perme Estimator (PPE) was suggested in 2012 and soon established itself as the gold standard for estimating net survival. This scoping review aims to know in which context this estimator is being used in the oncology area, what the authors point out as a justification for its use, and the limitations found. We searched PubMed, and the grey literature to answer the question: Have studies involving patients diagnosed with cancer used the PPE to estimate cancer-specific survival? How do they justify the use of the PPE and what are the limitations pointed out? Out of 295 screened, 85 studies were included in this review. The two main characteristics of the PPE mentioned by the studies as justification were the fact that it is an unbiased estimator (83.5%) and that it produces comparable estimates among populations with different mortality rates from causes other than cancer (36.47%). No study pointed to a limitation due to the use of PPE. As a conclusion, the Pohar Perme Estimator is the gold standard for estimating net survival and should be more used in oncology, especially when dealing with population-based studies where the follow-up time is long, making high the probability of death from causes other than cancer. |
id |
UFRGS-2_cad93421a70808d6029b79ac626d035c |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/245374 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Nagamine, Camila Macedo LimaGoulart, Bárbara Niegia Garcia deZiegelmann, Patricia Klarmann2022-07-23T05:02:13Z20222072-6694http://hdl.handle.net/10183/245374001145665Population-based net survival is an important tool for assessing prognostic advances. The unbiased Pohar Perme Estimator (PPE) was suggested in 2012 and soon established itself as the gold standard for estimating net survival. This scoping review aims to know in which context this estimator is being used in the oncology area, what the authors point out as a justification for its use, and the limitations found. We searched PubMed, and the grey literature to answer the question: Have studies involving patients diagnosed with cancer used the PPE to estimate cancer-specific survival? How do they justify the use of the PPE and what are the limitations pointed out? Out of 295 screened, 85 studies were included in this review. The two main characteristics of the PPE mentioned by the studies as justification were the fact that it is an unbiased estimator (83.5%) and that it produces comparable estimates among populations with different mortality rates from causes other than cancer (36.47%). No study pointed to a limitation due to the use of PPE. As a conclusion, the Pohar Perme Estimator is the gold standard for estimating net survival and should be more used in oncology, especially when dealing with population-based studies where the follow-up time is long, making high the probability of death from causes other than cancer.application/pdfengCancers (Basel). Basel, Switzerland : MDPI, 2009-. Vol. 14, no. 4 (2022), 3304, p. 1-9Análise de sobrevivênciaCâncerEpidemiologiaCancer survivalNet survivalCancer registriesEpidemiologyPohar Perme EstimatorNet survival in survival analyses for patients with cancer : a scoping reviewEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001145665.pdf.txt001145665.pdf.txtExtracted Texttext/plain29944http://www.lume.ufrgs.br/bitstream/10183/245374/2/001145665.pdf.txtea701a207892dd7f9f886eecf60d0d76MD52ORIGINAL001145665.pdfTexto completo (inglês)application/pdf423615http://www.lume.ufrgs.br/bitstream/10183/245374/1/001145665.pdf21f44010d03b481fd2267dbd03567fd9MD5110183/2453742022-07-24 04:51:20.215596oai:www.lume.ufrgs.br:10183/245374Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-07-24T07:51:20Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Net survival in survival analyses for patients with cancer : a scoping review |
title |
Net survival in survival analyses for patients with cancer : a scoping review |
spellingShingle |
Net survival in survival analyses for patients with cancer : a scoping review Nagamine, Camila Macedo Lima Análise de sobrevivência Câncer Epidemiologia Cancer survival Net survival Cancer registries Epidemiology Pohar Perme Estimator |
title_short |
Net survival in survival analyses for patients with cancer : a scoping review |
title_full |
Net survival in survival analyses for patients with cancer : a scoping review |
title_fullStr |
Net survival in survival analyses for patients with cancer : a scoping review |
title_full_unstemmed |
Net survival in survival analyses for patients with cancer : a scoping review |
title_sort |
Net survival in survival analyses for patients with cancer : a scoping review |
author |
Nagamine, Camila Macedo Lima |
author_facet |
Nagamine, Camila Macedo Lima Goulart, Bárbara Niegia Garcia de Ziegelmann, Patricia Klarmann |
author_role |
author |
author2 |
Goulart, Bárbara Niegia Garcia de Ziegelmann, Patricia Klarmann |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Nagamine, Camila Macedo Lima Goulart, Bárbara Niegia Garcia de Ziegelmann, Patricia Klarmann |
dc.subject.por.fl_str_mv |
Análise de sobrevivência Câncer Epidemiologia |
topic |
Análise de sobrevivência Câncer Epidemiologia Cancer survival Net survival Cancer registries Epidemiology Pohar Perme Estimator |
dc.subject.eng.fl_str_mv |
Cancer survival Net survival Cancer registries Epidemiology Pohar Perme Estimator |
description |
Population-based net survival is an important tool for assessing prognostic advances. The unbiased Pohar Perme Estimator (PPE) was suggested in 2012 and soon established itself as the gold standard for estimating net survival. This scoping review aims to know in which context this estimator is being used in the oncology area, what the authors point out as a justification for its use, and the limitations found. We searched PubMed, and the grey literature to answer the question: Have studies involving patients diagnosed with cancer used the PPE to estimate cancer-specific survival? How do they justify the use of the PPE and what are the limitations pointed out? Out of 295 screened, 85 studies were included in this review. The two main characteristics of the PPE mentioned by the studies as justification were the fact that it is an unbiased estimator (83.5%) and that it produces comparable estimates among populations with different mortality rates from causes other than cancer (36.47%). No study pointed to a limitation due to the use of PPE. As a conclusion, the Pohar Perme Estimator is the gold standard for estimating net survival and should be more used in oncology, especially when dealing with population-based studies where the follow-up time is long, making high the probability of death from causes other than cancer. |
publishDate |
2022 |
dc.date.accessioned.fl_str_mv |
2022-07-23T05:02:13Z |
dc.date.issued.fl_str_mv |
2022 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/245374 |
dc.identifier.issn.pt_BR.fl_str_mv |
2072-6694 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001145665 |
identifier_str_mv |
2072-6694 001145665 |
url |
http://hdl.handle.net/10183/245374 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Cancers (Basel). Basel, Switzerland : MDPI, 2009-. Vol. 14, no. 4 (2022), 3304, p. 1-9 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/245374/2/001145665.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/245374/1/001145665.pdf |
bitstream.checksum.fl_str_mv |
ea701a207892dd7f9f886eecf60d0d76 21f44010d03b481fd2267dbd03567fd9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1801225062207979520 |